A Prospective-Study of the Effects of Prolonged Timolol Therapy on Alpha-Adrenoceptor and Beta-Adrenoceptor and Angiotensin-II Receptor-Mediated Responses in Normal Subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN76842657

Enrollment

Registered

2004-01-23

Start date

1996-03-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System

Interventions

Timolol 10 mg twice daily or placebo for 14 days

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy males

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026